Amgen, Inc.

( )
AMGN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -1.09%345.740.0%$4309.25m
BNTXBioNTech SE -0.86%292.390.0%$812.11m
NVAXNovavax, Inc. -0.27%134.9979.4%$758.79m
AMGNAmgen, Inc. 0.51%208.681.4%$526.19m
REGNRegeneron Pharmaceuticals, Inc. 2.77%592.152.7%$478.99m
SNSSSunesis Pharmaceuticals, Inc. -0.80%6.210.7%$434.10m
GILDGilead Sciences, Inc. 0.09%67.731.0%$397.88m
CCXIChemoCentryx, Inc. -3.57%33.722.9%$386.50m
ILMNIllumina, Inc. -0.85%417.193.3%$357.19m
XLRNAcceleron Pharma, Inc. 0.00%173.785.3%$335.39m
OCGNOcugen, Inc. -2.03%9.150.0%$303.34m
VRTXVertex Pharmaceuticals, Inc. -0.50%184.071.9%$274.05m
BIIBBiogen, Inc. 0.44%271.121.8%$271.81m
XENEXenon Pharmaceuticals, Inc. -0.52%30.570.4%$164.85m
CRSPCRISPR Therapeutics AG -1.70%95.060.6%$159.07m

Company Profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, Aimovig, KANJINTI, EVENITY, AMGEVITA, AVSOLA, BLINCYTO, MVASI, Corlanor, Enbrel, EPOGEN, IMLYGIC, Kyprolis, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, Otezla, RIABNI, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.